drugset / Trial / NCT01303601

Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression

NCT01303601

Phase 4 Completed 68 enrolled China Medical University, China
RandomizedParallel-groupTriple-blindTreatment

Summary

Olanzapine may have some antidepressant properties and olanzapine monotherapy has been shown efficacy in bipolar depressive episodes in retrospective studies. However, there has been no prospective study about the monotherapy of olanzapine. The investigators conducted a randomized, placebo-controlled study to test the efficacy of olanzapine monotherapy for treatment of the depressed phase of bipolar disorder.

Timeline

Start
2009-01
Primary completion
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule 10 mg
Subject Olanzapine Small molecule 20 mg

Indications